Protocadherin-19 (PCDH19 or DEE9 or EFMR) Antibody

Protein Function

This antibody supports experimental designs that characterize Protocadherin-19 (DEE9) with interpretable controls and clear contrasts. Protocadherin-19 is a structural regulator of intercellular boundaries and tissue architecture. Plan positive and negative controls that match your model system, including perturbations expected to shift the target.

In some datasets and protocols, it is referenced by the gene symbol DEE9.

Experimental Applications

In cultured models, junctional readouts can change rapidly after calcium modulation or cytoskeletal perturbation. Time course design can be decisive when regulation is transient or compartment dependent.

Target-centric readouts can be framed around localization, relative abundance, or complex behavior, depending on the question you are testing. Planar polarity studies may connect this target to directional signaling and cytoskeletal alignment.

Common experimental questions that benefit from target tracking include:

• changes in complex assembly with scaffold or adaptor proteins
• comparative profiling across cell states or perturbations
• co-localization patterns with cytoskeletal elements

Workflow Perspective

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior. To keep comparisons consistent, align sample preparation steps and define a clear baseline for each series. Predefine acceptance criteria for controls before collecting the full dataset.

When interpreting Protocadherin-19, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

The regular format format fits designs where Protocadherin-19 (DEE9) is evaluated with deliberate controls and careful comparisons.